Plzf limits enhancer activity during hematopoietic progenitor aging

HIGHLIGHTS

• who: PLZF limits enhancer activity and collaborators from the Epigenetic Factors in Normal and Malignant Hematopoiesis, Aix Marseille Université, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France, Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan, Gustave Roussy, Université Paris-Saclay, Inserm, CNRS Villejuif, France, Aix Marseille Université, CNRS, IBDM, Marseille, France and , Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan have published the paper: PLZF limits enhancer activity during hematopoietic progenitor aging, in the Journal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.